Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity

Over the past 2 decades, therapies based on mesenchymal stem cells (MSC) have been tested to treat several types of diseases in clinical studies, due to their potential for tissue repair and regeneration. Currently, MSC-based therapy is considered a biologically safe procedure, with the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezquer, Fernando E., Ezquer, Marcelo E., Vicencio, Jose M., Calligaris, Sebastián D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308221/
https://www.ncbi.nlm.nih.gov/pubmed/27294313
http://dx.doi.org/10.1080/19336918.2016.1197480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308221/
https://www.ncbi.nlm.nih.gov/pubmed/27294313
http://dx.doi.org/10.1080/19336918.2016.1197480

Ejemplares similares